Hermans C - Search Results

1

Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A.

Agarwal S, Hermans C, Miesbach W, Peyvandi F, Sidonio R Jr, Osmond D, Newman V, Henshaw J, Pipe S. Agarwal S, et al. Among authors: hermans c. Haemophilia. 2024 Jul;30(4):905-913. doi: 10.1111/hae.15025. Epub 2024 Apr 29. Haemophilia. 2024. PMID: 38684460 Free article.

2

Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations.

Hermans C, Altisent C, Batorova A, Chambost H, De Moerloose P, Karafoulidou A, Klamroth R, Richards M, White B, Dolan G; European Haemophilia Therapy Standardisation Board. Hermans C, et al. Haemophilia. 2009 May;15(3):639-58. doi: 10.1111/j.1365-2516.2008.01950.x. Haemophilia. 2009. PMID: 19444969 Review.

3

The international factor IX treatment network survey.

Berntorp E, Shapiro AD, Waters J, Astermark J; International Factor IX Treatment Network. Berntorp E, et al. Haemophilia. 2012 May;18(3):e60-2. doi: 10.1111/j.1365-2516.2012.02767.x. Epub 2012 Mar 8. Haemophilia. 2012. PMID: 22404549 No abstract available.

4

FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies.

Fischer K, Iorio A, Hollingsworth R, Makris M; EUHASS collaborators. Fischer K, et al. Haemophilia. 2016 Jan;22(1):e36-8. doi: 10.1111/hae.12764. Epub 2015 Jul 24. Haemophilia. 2016. PMID: 26208036 No abstract available.

5

Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studies.

Mahlangu J, Jiménez-Yuste V, Ventriglia G, Niggli M, Barlera S, Hermans C, Lehle M, Chowdary P, Jew L, Windyga J, Frenzel L, Schmitt C, Castaman G, Pipe SW. Mahlangu J, et al. Among authors: hermans c. Res Pract Thromb Haemost. 2024 Mar 1;8(2):102364. doi: 10.1016/j.rpth.2024.102364. eCollection 2024 Feb. Res Pract Thromb Haemost. 2024. PMID: 38559572 Free PMC article.

6

Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A.

Holme PA, Blatný J, Chowdary P, Lassila R, O'Connell N, Hermans C, Álvarez Román MT, Négrier C, Coppola A, Oldenburg J. Holme PA, et al. Among authors: hermans c. Haemophilia. 2024 Sep;30(5):1109-1114. doi: 10.1111/hae.15031. Epub 2024 Jul 10. Haemophilia. 2024. PMID: 38986684 Review.

7

Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS).

Fischer K, Lassila R, Peyvandi F, Gatt A, Gouw SC, Hollingsworth R, Lambert T, Kaczmarek R, Carbonero D, Makris M; European HAemophilia Safety Surveillance (EUHASS) participants. Fischer K, et al. Res Pract Thromb Haemost. 2024 May 27;8(4):102461. doi: 10.1016/j.rpth.2024.102461. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 39026659 Free PMC article.

8

Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE Study.

Oldenburg J, Hay C, Peyvandi F, Tagliaferri A, Holme PA, Álvarez-Román MT, Biron-Andréani C, Malmström H, Bystrická L, Lethagen S; A‐SURE Study Group. Oldenburg J, et al. Eur J Haematol. 2024 Oct 21. doi: 10.1111/ejh.14309. Online ahead of print. Eur J Haematol. 2024. PMID: 39434416

9

Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.

Dunn A, Dargaud Y, Abajas Y, Carcao M, Castaman G, Giermasz A, Hermans C, Jiménez-Yuste V, Lewandowska M, Mahlangu J, Meeks S, Miesbach W, Recht M, Salinas V, Chrisentery-Singleton T, Bonzo D, Mitchell IS, Wilkinson TA, Young G. Dunn A, et al. Among authors: hermans c. Haemophilia. 2024 Dec 15. doi: 10.1111/hae.15109. Online ahead of print. Haemophilia. 2024. PMID: 39676340

10

Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors.

Gringeri A, Fischer K, Karafoulidou A, Klamroth R, López-Fernández MF, Mancuso E; European Haemophilia Treatment Standardisation Board (EHTSB). Gringeri A, et al. Haemophilia. 2011 Jul;17(4):630-5. doi: 10.1111/j.1365-2516.2010.02467.x. Epub 2011 Feb 15. Haemophilia. 2011. PMID: 21323801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters